Batu Biologics Recruits Cancer Immunologist to Scientific Advisory Board

Collaboration of IND-enabling experiments for ValloVax™ with Dr. Fang November 19, 2014 Batu Biologics, an immunotherapy company working to develop ValloVax, an anti-angiogenic cancer vaccine, announced today the addition of Dr. Deyu Fang to its Scientific Advisory Board. Deyu Fang, Ph.D. is an immunologist and associate professor working in the Department of Pathology at Northwestern University Feinberg School of Medicine. …